healthŌme and GalenusRx Forge Strategic Partnership to Launch Genomics-based Personalized Medication Safety Program

Deprescribing in High-Risk Patients: A Proven Path to ADE Prevention

September 10, 2024 2:00 pm

Overview

Managing polypharmacy among high-risk patients is crucial to improving outcomes and controlling costs. Join us for an in-depth webinar on targeted deprescribing as a strategic approach to reducing polypharmacy and preventing adverse drug events (ADEs).

This session is designed for ACO leaders and healthcare providers committed to optimizing care within the framework of value-based care.

Learning Objectives

  • Recognize the challenges polypharmacy presents to attributed patient outcomes and overall healthcare costs.
  • Understand how deprescribing can be an effective strategy to mitigate polypharmacy.
  • Recognize practical methods for deprescribing using the APPRAISE solution within your care teams, targeting patients with high-risk medication regimens.
  • Demonstrate deprescribing techniques through sample patient cases.
GalenusRx Webinar

dates and location

Additional Information

Calvin H. Knowlton, PhD

Executive Chairperson, Co-Founder & Co-CEO

Desiree Massari, PharmD, BCGP, CCP

Operations Manager, Precision Pharmacotherapy Services

Vicente Diaz-Gonzalez, MD

Clinic Medical Director